Systematic identification of non-coding pharmacogenomic landscape in cancer

In this study the authors build lncRNA-drug response models for 265 anti-cancer agents across 27 cancer types. They report their cancer cell line based lncRNA EN-models are able to effectively predict therapeutic outcome for breast cancer, ovarian cancer, endometrial cancer and stomach cancer patien...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yue Wang, Zehua Wang, Jieni Xu, Jiang Li, Song Li, Min Zhang, Da Yang
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
Q
Accès en ligne:https://doaj.org/article/fee06fe94cdb4d0d90df7243859b2fbc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:In this study the authors build lncRNA-drug response models for 265 anti-cancer agents across 27 cancer types. They report their cancer cell line based lncRNA EN-models are able to effectively predict therapeutic outcome for breast cancer, ovarian cancer, endometrial cancer and stomach cancer patients.